Pluristem Announces Closing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock
HAIFA, Israel, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced the closing of its previously announced firm commitment underwritten public offering of 11,000,000 units, with each unit consisting of one share of the Company's common stock and one warrant to purchase 0.4 of a share of common stock, at a purchase price of $3.25 per unit.
The underwriters have exercised in full their over-allotment option to purchase an additional 1,650,000 shares of the Company's common stock and additional warrants to purchase up to 660,000 shares of the Company's common stock. The net proceeds to the Company are expected to be approximately $38 million, assuming no exercise of the warrants and after deducting underwriting commissions and discounts and estimated offering expenses payable by the Company.
Oppenheimer & Co. Inc. acted as the sole bookrunner and Needham & Company, LLC acted as co-lead manager for the offering. Maxim Group LLC and National Securities Corp participated in the selling group for the offering. Leader Capital Markets Ltd. advised the Company as did Roth Capital Partners, LLC.The securities described above were sold by Pluristem pursuant to a "shelf" registration statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC) on December 22, 2010 and declared effective by the SEC on January 11, 2011. A prospectus supplement in connection with the offering, dated January 27, 2011, was filed with the SEC on January 28, 2011 and is available on the SEC's website at http://www.sec.gov . A copy of the prospectus supplement and the accompanying base prospectus may be obtained by sending a request to Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 300 Madison Avenue, 4th Floor, New York, NY, 10017, Telephone number: (212) 667-8563, Email:EquityProspectus@opco.com. This press release shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV